Treatment and composition for wound healing

a technology of composition and wound healing, applied in the direction of blood coagulation/fibrinolysis factor, protease inhibitor, animal/human protein, etc., can solve the problems of inability to heal venous stasis, poor understanding of the molecular mechanisms of impaired wound healing, and failure to heal the venous stasis of most clinical trials using growth factors/cytokines

Inactive Publication Date: 2004-09-09
SYDNEY THE UNIV OF
View PDF9 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0050] The APC and / or protein C utilised in the present invention may be obtained by purification from a suitable source (eg blood taken from humans or other animals) or produced by standard recombinant DNA techniques such as is described in, for example, Maniatis, T. et al., Molecular Cloning: a laboratory manual, Second Edition, Cold Spring Harbor Laboratory Press. Recombinant APC or protein C may incorporate modifications (eg amino acid substitutions, deletions, and additions of heterologous amino add sequences), which may, for example, enhance biological activity or expression of the respective protein. However, preferably, the present invention utilises human APC and / or protein C. The APC and / or protein C may also be glycosylated by methods well known in the art and which may comprise enzymatic and non-enzymatic means.

Problems solved by technology

Wounds may be caused by accidents or by surgical procedures.
Despite intense investigation, the molecular mechanisms associated with impaired wound healing are poorly understood.
However, on the whole, results from most clinical trials using growth factors / cytokines have been disappointing.
For example, EGF failed to heal venous stasis ulcers and IL-1 failed to treat pressure sores effectively (2).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Treatment and composition for wound healing
  • Treatment and composition for wound healing
  • Treatment and composition for wound healing

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0078] APC Promotion of Endothelial Wound Repair

[0079] Activated protein C (APC) was tested for its ability to promote repair of endothelial wounding using a modification of an in vitro assay, as described previously (19). Briefly, confluent microvascular endothelial cells (FSE) from neonatal foreskins were cultured for 5 days in 24-well culture plates in growth medium (Biorich plus 50 .mu.g / ml heparin, 50 .mu.g / ml endothelial cell growth supplement and 5% human serum). The endothelial monolayers were wounded by a single stroke across the diameter of the well with a pipette tip. The media and dislodged cells were then aspirated, and the plates rinsed with Hanks buffer. Fresh growth medium was added to the plates along with APC at various concentrations or the potent tumour-promoting angiogenic factor, phorbol myristate acetate (PMA) (10 ng / ml) and the cells were incubated at 37 degrees C. After 24 hr, the width of the wound was visualised microscopically and results at different dos...

example 2

[0080] APC Promotion of Angiogenesis

[0081] In view of the ability of APC to activate gelatinase A and promote endothelial wounding, APC was investigated as to whether it could promote angiogenesis. APC was added to the chicken embryo chorio-allantoic membrane (CAM) assay using gelatin sponges (Gelfoam). Sponges were cut to approximately 2 mm.times.2 mm. Five .mu.g APC in phosphate buffered saline (PBS) or PBS alone was added to gelatin sponges which were subsequently placed on the 9 day old CAM, as previously described (34). The CAMs were inspected daily and on day 14 were photographed and fixed for histological sectioning. Macroscopically, on day 14, the APC-treated gelatin sponges were surrounded by blood vessels that grew radially inwards towards the sponge in a "spoke-wheel" pattern (data not shown). In contrast, gelatin sponges treated with PBS had no surrounding vascular formation. Histological sections showed that APC-treated sponges were infiltrated with many new blood vesse...

example 3

[0082] APC Promotion of Wound Healing

[0083] In view of APC's ability to stimulate endothelial migration and enhance re-epithelialisation, fibroblast invasion and angiogenesis, APC was examined for a capacity to improve wound healing in a rat model. Sprague-Dawley rats were anaesthetised and four full-thickness wounds were excised, using a 8 mm punch biopsy, on the back of the rat, exposing the underlying dorsolateral skeletal muscle fascia. Hemostasis was achieved by even compression with sterile gauze. APC was diluted in isotonic, sterile, pyrogen-free saline solution and each excision was treated with a 50 .mu.l topical application of sterile, pyrogen-free saline solution or saline containing 20 .mu.g APC. The wounds were left open with no dressing and rats caged one per cage. Wound closure was assessed visually and after 40 hr, 4 days and 7 days. At each timepoint the wounds were digitally photographed using a Nikon Coolpix 950, with a distance calibration scale in the frame. The...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Timeaaaaaaaaaa
Weightaaaaaaaaaa
Login to View More

Abstract

A method and medicament for promoting wound healing in a subject is disclosed. The medicament comprises an effective amount of an agent comprising one or more of; (i) an activated protein C (APC), (ii) a functional fragment of an APC, (iii) an APC mimetic compound, and (iv) protein C. Delivery systems including gels, sponges, gauzes and meshes incorporating the agent for topical administration are also described.

Description

[0001] The present invention relates to the field of medicine and, more particularly, to wound healing and methods and compositions for promoting wound healing. In a particular application of the present invention, activated protein C (APC) is administered to a slow healing wound by, for example, topical application.BACKGROUND TO THE INVENTION[0002] Wounds are internal or external bodily injuries or lesions caused by physical means, such as mechanical, chemical, viral, bacterial, or thermal means, which disrupt the normal continuity of structures. Such bodily injuries include contusions, wounds in which the skin is unbroken, incisions, wounds in which the skin is broken by a cutting instrument, lacerations, and wounds in which the skin is broken by a dull or blunt instrument. Wounds may be caused by accidents or by surgical procedures.[0003] The healing of wounds is a complex process involving a number of stages. These include; 1) coagulation, which begins immediately after injury; ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/36A61K38/00A61K38/43A61K38/48A61P9/10A61P17/02A61P19/04A61P19/08A61P29/00A61P43/00
CPCA61K9/0048A61K38/4866A61P17/02A61P19/04A61P19/08A61P29/00A61P43/00A61P9/10
InventorJACKSON, CHRISTOPHER JOHNSAMBROOK, PHILIP NEIL
OwnerSYDNEY THE UNIV OF